| P50 | author | Vaughn S. Cooper | Q41050411 |
| P2093 | author name string | Kathy H Y Shair | |
| | Akhil Reddy | |
| P2860 | cites work | Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan | Q78608443 |
| | LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice | Q81398990 |
| | Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells | Q24294987 |
| | Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma | Q24298635 |
| | Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers | Q24541318 |
| | Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers | Q24561854 |
| | The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB | Q24646694 |
| | Epstein-Barr virus and virus human protein interaction maps | Q24675055 |
| | Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus | Q26752331 |
| | Adoptive T-Cell Immunotherapy | Q26782845 |
| | Microvesicles and viral infection | Q26823408 |
| | Novel mechanisms of EBV-induced oncogenesis | Q27006524 |
| | Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma | Q27016002 |
| | Epithelial-mesenchymal transitions in tumour progression | Q27860487 |
| | Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees | Q27861060 |
| | Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells | Q45796774 |
| | Chemical carcinogen Epstein-Barr virus (EBV) synergism: EBV genome amplification and site-specific mutation during transformation | Q45846486 |
| | Epstein-Barr virus infection and replication in a human epithelial cell system | Q45880200 |
| | Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry | Q47239784 |
| | Cadherin 6 is activated by Epstein-Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma | Q47248660 |
| | Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus. | Q47559100 |
| | Well-differentiated human airway epithelial cell cultures. | Q47910046 |
| | The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells. | Q48038156 |
| | C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes | Q50045673 |
| | The interactome of EBV LMP1 evaluated by proximity-based BioID approach | Q50064513 |
| | Viral Entry. | Q50955999 |
| | The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. | Q54773119 |
| | Epstein-Barr virus-associated lymphomas | Q56930876 |
| | Oral hairy leukoplakia | Q68465807 |
| | Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy | Q73271294 |
| | Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis | Q77340409 |
| | Exosomal communication goes viral | Q28083133 |
| | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins | Q28117120 |
| | Cadherin switch in tumor progression | Q28262569 |
| | Epstein-Barr virus-encoded latent membrane protein 1 impairs G2 checkpoint in human nasopharyngeal epithelial cells through defective Chk1 activation | Q28728022 |
| | MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets | Q29616345 |
| | Epstein-Barr virus: 40 years on | Q29617969 |
| | Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells | Q30587658 |
| | EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas | Q30837949 |
| | Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9 | Q33265945 |
| | Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors | Q33866046 |
| | Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. | Q33900772 |
| | VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA | Q33971399 |
| | The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases | Q34099074 |
| | Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes | Q34171808 |
| | Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient | Q34228526 |
| | The DNA damage response in viral-induced cellular transformation | Q34246710 |
| | Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. | Q34262322 |
| | Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. | Q34271121 |
| | Human tumor virus utilizes exosomes for intercellular communication. | Q34377767 |
| | LMP1 structure and signal transduction | Q34415978 |
| | Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations | Q34549536 |
| | Epstein-Barr virus replicating in epithelial cells | Q34581119 |
| | Efficient replication of Epstein-Barr virus in stratified epithelium in vitro | Q34581330 |
| | Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells | Q34598541 |
| | LMP1-induced cell death may contribute to the emergency of its oncogenic property. | Q34699997 |
| | LMP1 strain variants: biological and molecular properties. | Q34717145 |
| | Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma | Q34745799 |
| | Signalling shortcuts: cell-surface receptors in the nucleus? | Q34810206 |
| | Epstein-Barr virus in the pathogenesis of NPC. | Q35008870 |
| | The significance of LMP1 expression in nasopharyngeal carcinoma | Q35008886 |
| | Efficient immortalization of primary nasopharyngeal epithelial cells for EBV infection study | Q35027926 |
| | Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells | Q35119824 |
| | Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling | Q35122447 |
| | Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology | Q35363383 |
| | MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling | Q35635449 |
| | The pathogenesis of Epstein-Barr virus persistent infection. | Q38107595 |
| | The role of Epstein-Barr virus in epithelial malignancies | Q38253914 |
| | Characterization of the latent membrane protein 1 signaling complex of Epstein-Barr virus in the membrane of mammalian cells with bimolecular fluorescence complementation | Q38427527 |
| | Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 |
| | Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types. | Q38596342 |
| | Nasopharyngeal Carcinoma: An Evolving Role for the Epstein-Barr Virus | Q38596356 |
| | Viral effects on the content and function of extracellular vesicles. | Q38666881 |
| | CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-κB Signaling | Q38782732 |
| | Epstein-Barr virus LMP1 induces focal adhesions and epithelial cell migration through effects on integrin-α5 and N-cadherin | Q38826798 |
| | Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids | Q38855080 |
| | The genomic landscape of nasopharyngeal carcinoma | Q38982367 |
| | The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells | Q38994418 |
| | Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1. | Q39115333 |
| | Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells. | Q39124304 |
| | Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells | Q39578660 |
| | Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdelta | Q39595269 |
| | Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. | Q39604074 |
| | Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines | Q39679329 |
| | Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas | Q39683197 |
| | Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay | Q39684889 |
| | A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 |
| | Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. | Q39749474 |
| | Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification | Q39852028 |
| | Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. | Q39917652 |
| | Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma | Q39952661 |
| | Epstein-Barr virus infection and nasopharyngeal carcinoma | Q40046633 |
| | HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis | Q40050669 |
| | A new diagnostic marker for secreted Epstein-Barr virus encoded LMP1 and BARF1 oncoproteins in the serum and saliva of patients with nasopharyngeal carcinoma | Q40085468 |
| | Molecular diversity of IgG responses to Epstein-Barr virus proteins in asymptomatic Epstein-Barr virus carriers | Q40088154 |
| | Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes | Q40124366 |
| | Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens | Q40150612 |
| | Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas | Q40259681 |
| | Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 |
| | Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells | Q40339509 |
| | Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. | Q40399583 |
| | Generation and Infection of Organotypic Cultures with Epstein-Barr Virus | Q40441067 |
| | Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. | Q40470698 |
| | Epstein-Barr virus immortalizing genes | Q40540784 |
| | Phenotypic alterations induced by the Hong Kong-prevalent Epstein-Barr virus-encoded LMP1 variant (2117-LMP1) in nasopharyngeal epithelial cells | Q40577418 |
| | The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity | Q40814583 |
| | Direct immunosuppressive effects of EBV-encoded latent membrane protein 1. | Q40870284 |
| | CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells | Q40872749 |
| | Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains | Q40936386 |
| | Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production | Q40951743 |
| | Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers | Q40957203 |
| | Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China | Q41729450 |
| | Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression | Q41981419 |
| | Etiological factors of nasopharyngeal carcinoma | Q42231417 |
| | Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas | Q42262852 |
| | Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma | Q42265650 |
| | The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation | Q43610021 |
| | Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo | Q43820693 |
| | Burkitt lymphoma and the discovery of Epstein-Barr virus | Q43953860 |
| | Biology of Epstein-Barr virus during infectious mononucleosis | Q43971482 |
| | Expression of Epstein‐Barr virus‐encodedLMP1andhTERTextends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells | Q44232903 |
| | Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia | Q44929567 |
| | Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia | Q44951056 |
| | Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation | Q45288192 |
| | Tetraspanin CD63 bridges autophagic and endosomal processes to regulate exosomal secretion and intracellular signaling of Epstein-Barr virus LMP1. | Q45323701 |
| | Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy | Q45360118 |
| | Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma. | Q45360289 |
| | Epstein-Barr virus (EBV) infection in epithelial cells in vivo: rare detection of EBV replication in tongue mucosa but not in salivary glands | Q45532916 |
| | Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China | Q45756839 |
| | Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. | Q45775433 |
| | Sequence variation in the Epstein-Barr virus latent membrane protein 1. | Q45782895 |
| | Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder | Q45788362 |
| | Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection | Q35641421 |
| | Focus on nasopharyngeal carcinoma | Q35773862 |
| | Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells | Q35797164 |
| | Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia | Q35798133 |
| | The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. | Q35841701 |
| | The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat | Q35842451 |
| | LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1 | Q35861199 |
| | Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells. | Q35861281 |
| | The role of miRNAs and EBV BARTs in NPC. | Q35924359 |
| | The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1 | Q36006767 |
| | Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells | Q36055637 |
| | Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation | Q36363843 |
| | Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells | Q36483613 |
| | The Epstein-Barr virus encoded LMP1 oncoprotein modulates cell adhesion via regulation of activin A/TGFβ and β1 integrin signalling | Q36500037 |
| | Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains | Q36559612 |
| | Epstein-Barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation | Q36559750 |
| | Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation | Q36575274 |
| | Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma | Q36742929 |
| | Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes | Q36782491 |
| | Potential selection of LMP1 variants in nasopharyngeal carcinoma | Q36944141 |
| | EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. | Q36994005 |
| | Immortalization of human lymphocytes by Epstein-Barr virus | Q37000329 |
| | Human airway epithelial cell culture to identify new respiratory viruses: coronavirus NL63 as a model | Q37165380 |
| | Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. | Q37323204 |
| | Epstein-Barr Virus encoded LMP1 regulates cyclin D1 promoter activity by nuclear EGFR and STAT3 in CNE1 cells | Q37350214 |
| | Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. | Q37408369 |
| | Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. | Q37453542 |
| | Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma | Q37575613 |
| | Culturing of human nasal epithelial cells at the air liquid interface | Q37610749 |
| | STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation | Q37687614 |
| | The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers | Q37705818 |
| | Epstein-Barr virus genetics: talking about the BAC generation | Q37856451 |
| | The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). | Q37976235 |
| | The biology of EBV infection in human epithelial cells | Q38002035 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P577 | publication date | 2018-03-21 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. | |
| P478 | volume | 10 | |